Weerts; Johan Erwin Edmond

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weerts; Johan Erwin Edmond.The latest application filed is for "pyrazolyl quinoxaline kinase inhibitors".

Company Profile

6.12.15

Weerts; Johan Erwin Edmond - Beerse BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazolyl Quinoxaline Kinase Inhibitors App 20220135544 - SAXTY; Gordon ; et al.	2022-05-05
Process for the preparation of a diarylthiohydantoin compound Grant 11,040,953 - Ben Haim , et al. June 22, 2	2021-06-22
Process For The Preparation Of A Diarylthiohydantoin Compound App 20200354334 - Ben Haim; Cyril ; et al.	2020-11-12
Processes for the preparation of a diarylthiohydantoin compound Grant 10,723,714 - Ben Haim , et al.	2020-07-28
Pyrazolyl Quinoxaline Kinase Inhibitors App 20200131153 - SAXTY; Gordon ; et al.	2020-04-30
Processes For The Preparation Of A Diarylthiohydantoin Compound App 20190284156 - Ben Haim; Cyril ; et al.	2019-09-19
Processes for the preparation of a diarylthiohydantoin compound Grant 10,316,015 - Ben Haim , et al.	2019-06-11
Processes For The Preparation Of A Diarylthiohydantoin Compound App 20190135775 - Ben Haim; Cyril ; et al.	2019-05-09
Pyrazolyl Quinoxaline Kinase Inhibitors App 20180127397 - SAXTY; Gordon ; et al.	2018-05-10
Pyrazolyl quinoxaline kinase inhibitors Grant 9,850,228 - Saxty , et al. December 26, 2	2017-12-26
Pyrazolyl Quinoxaline Kinase Inhibitors App 20160311800 - SAXTY; Gordon ; et al.	2016-10-27
Pyrazolyl quinoxaline kinase inhibitors Grant 9,464,071 - Saxty , et al. October 11, 2	2016-10-11
Pyrazolyl Quinoxaline Kinase Inhibitors App 20150105368 - SAXTY; Gordon ; et al.	2015-04-16
Mono-hydrochloric salts of an inhibitor of histone deacetylase Grant 8,759,519 - Dickens , et al. June 24, 2	2014-06-24
Imidazo[1,2-b]pyridazine derivatives and their use as PDE10 inhibitors Grant 8,716,282 - Pastor-Fernandez , et al. May 6, 2	2014-05-06
Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3- -yl]methyl}quinoline Grant 8,629,144 - Govaerts , et al. January 14, 2	2014-01-14
Pyrazolyl Quinazoline Kinase Inhibitors App 20130072457 - Saxty; Gordon ; et al.	2013-03-21
Mono-hydrochloric Salts Of An Inhibitor Of Histone Deacetylase App 20120289527 - Dickens; Julius W.J. ; et al.	2012-11-15
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS App 20110269752 - Pastor-Fernandez; Joaquin ; et al.	2011-11-03
Polymorphic and hydrate forms, salts and process for preparing 6-quinoline App 20100197912 - Govaerts; Tom Cornelis Hortense ; et al.	2010-08-05
Mono-hydrochloric Salts Of An Inhibitor Of Histone Deacetylase App 20100130523 - Dickens; Julius W.J. ; et al.	2010-05-27
Mandelates salts of substituted tetracyclic tetrahydrofuran derivatives Grant 7,317,115 - Medaer , et al. January 8, 2	2008-01-08
Novel mandelates salts of substituted tetracyclic tetrahydrofuran derivatives App 20050085533 - Medaer, Bart Petrus Anna Maria Jozef ; et al.	2005-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.